"Penicillamine" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
3-Mercapto-D-valine. The most characteristic degradation product of the penicillin antibiotics. It is used as an antirheumatic and as a chelating agent in Wilson's disease.
| Descriptor ID |
D010396
|
| MeSH Number(s) |
D02.886.030.786 D12.125.166.786
|
| Concept/Terms |
Penicillamine- Penicillamine
- Mercaptovaline
- D-Penicillamine
- D Penicillamine
- Dimethylcysteine
- beta,beta-Dimethylcysteine
- beta,beta Dimethylcysteine
- D-3-Mercaptovaline
- D 3 Mercaptovaline
|
Below are MeSH descriptors whose meaning is more general than "Penicillamine".
Below are MeSH descriptors whose meaning is more specific than "Penicillamine".
This graph shows the total number of publications written about "Penicillamine" by people in this website by year, and whether "Penicillamine" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 0 | 1 | 1 |
| 1997 | 0 | 1 | 1 |
| 2000 | 2 | 1 | 3 |
| 2003 | 1 | 0 | 1 |
| 2008 | 1 | 0 | 1 |
| 2015 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Penicillamine" by people in Profiles.
-
Mendoza FA, Bai R, Kebede AG, Jimenez SA. Severe eosinophilic fasciitis: comparison of treatment with D-penicillamine plus corticosteroids vs. corticosteroids alone. Scand J Rheumatol. 2016; 45(2):129-34.
-
Derk CT, Huaman G, Jimenez SA. A retrospective randomly selected cohort study of D-penicillamine treatment in rapidly progressive diffuse cutaneous systemic sclerosis of recent onset. Br J Dermatol. 2008 May; 158(5):1063-8.
-
Derk CT, Jimenez SA. Goodpasture-like syndrome induced by D-penicillamine in a patient with systemic sclerosis: report and review of the literature. J Rheumatol. 2003 Jul; 30(7):1616-20.
-
Studer RK, Levicoff E, Georgescu H, Miller L, Jaffurs D, Evans CH. Nitric oxide inhibits chondrocyte response to IGF-I: inhibition of IGF-IRbeta tyrosine phosphorylation. Am J Physiol Cell Physiol. 2000 Oct; 279(4):C961-9.
-
Gao F, Christopher TA, Lopez BL, Friedman E, Cai G, Ma XL. Mechanism of decreased adenosine protection in reperfusion injury of aging rats. Am J Physiol Heart Circ Physiol. 2000 Jul; 279(1):H329-38.
-
Shapiro M, Jimenez S, Werth VP. Pemphigus vulgaris induced by D-penicillamine therapy in a patient with systemic sclerosis. J Am Acad Dermatol. 2000 Feb; 42(2 Pt 1):297-9.
-
Lopez BL, Liu GL, Christopher TA, Ma XL. Peroxynitrite, the product of nitric oxide and superoxide, causes myocardial injury in the isolated perfused rat heart. Coron Artery Dis. 1997 Mar-Apr; 8(3-4):149-53.
-
Ma XL, Lopez BL, Christopher TA, Birenbaum DS, Vinten-Johansen J. Exogenous NO inhibits basal NO release from vascular endothelium in vitro and in vivo. Am J Physiol. 1996 Nov; 271(5 Pt 2):H2045-51.
-
Lopez BL, Christopher TA, Yue TL, Ruffolo R, Feuerstein GZ, Ma XL. Carvedilol, a new beta-adrenoreceptor blocker antihypertensive drug, protects against free-radical-induced endothelial dysfunction. Pharmacology. 1995 Sep; 51(3):165-73.
-
Christopher TA, Ma XL, Lefer AM. Beneficial actions of S-nitroso-N-acetylpenicillamine, a nitric oxide donor, in murine traumatic shock. Shock. 1994 Jan; 1(1):19-24.